This article reviews the role of inflammation in bladder dysfunction, and the potential for prostaglandins to play a contributing role. If this is the case, it presents this receptor system as a future therapeutic target, and also enhances our knowledge into the mechanisms underlying lower urinary tract function.
Copyright © Continence Foundation of Australia 2020
The final published version reprinted with permission from the publisher.
|Number of pages||3|
|Journal||Australian and New Zealand Continence Journal|
|Publication status||Published - 1 Sept 2020|